References
- MacNee W. Chronic bronchitis and emphysema. In: Seaton A, Seaton D, Leitch A G, eds. Crofton and Douglas's Respiratory Diseases. London: Blackwell Science Ltd., 2000:616–695.
- Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.Br Med J 2000; 320:1297–1303. [CSA]
- The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.N Engl J Med 2000; 343:1902–1909. [CSA], [CROSSREF]
- Pauwels R A, Löfdahl C G, Laitinen L A, Schouten J P, Postma D S, Pride N B, Ohlsson S V. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.N Engl J Med 1999; 340(25):1948–1953. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.Lancet 1999; 353:1819–1823. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study.Lancet 1997; 349(9064):1498–1504. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence.Chest Feb., 2000; 117(2 Suppl):1S–4S. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide.Monaldi Arch Chest Dis 2001; 56(3):261–264. [PUBMED], [INFOTRIEVE], [CSA]
- American Thoracic Society. European Respiratory Society: Standards for the Diagnosis and Management of Patients with COPD. www.thoracic.org/copd.
- Siafakas N M, Vermeire P, Pride N B, Paoletti P, Gibson J, Howard P, Yernault J C, Decramer M, Higenbottam T, Postma D S, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.Eur Respir J 1995; 8:1398–1420. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. In: NHLBI/WHO Workshop Report. NIH Publication 2701, Bethesda: U.S. Department of Health and Human Services, April 2001, (Updated 2003).
- BTS guidelines for the management of chronic obstructive pulmonary disease.Thorax 1997; 52(Suppl 5):S1–S28. [CSA]
- NICE Guideline No. 12: Chronic Obstructive Pulmonary Disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.Thorax 2004; 59(Suppl 1):i1–i232. [CSA], [CROSSREF]
- Laitinen L A, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998–2007.Respir Med May, 1999; 93(5):297–332. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mahler D A, Wire P, Horstman D, Chang C N, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease.Am J Respir Crit Care Med Oct. 15, 2002; 166(8):1084–1091. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.Eur Respir J Jan., 2003; 21(1):74–81. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Trial of inhaled steroids and long-acting beta2 agonists study group: combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.Lancet Feb. 8, 2003; 361(9356):449–456., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mannino D M, Brown C, Giovino G A. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data.Am J Respir Crit Care Med Sep., 1997; 156(3 Pt 1):814–818. [PUBMED], [INFOTRIEVE], [CSA]
- Gulsvik A. Mortality in and prevalence of chronic obstructive pulmonary disease in different parts of Europe.Monaldi Arch Chest Dis 1999; 54(2):160–162. [PUBMED], [INFOTRIEVE], [CSA]
- Pena V S, Miravitlles M, Gabriel R, Jimenez-Ruiz C A, Villasante C, Masa J F, Viejo J L, Fernandez-Fau L. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.Chest 2000; 118(4):981–989. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stang P, Lydick E, Silberman C, Kempel A, Keating E T. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.Chest 2000; 117(5 Suppl 2):354S–359S. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Järvinen K A, Pätiälä J, Thomander K. Frequency of obstructive pulmonary emphysema.Ann Med Intern Fenn 1960; 49:301–306. [CSA]
- Huhti E. Prevalence of respiratory symptoms, chronic bronchitis and pulmonary emphysema in a Finnish rural population. Field survey of age group 40–64 in the Harjavalta area.Acta Tuberc Pneumol Scand 1965, Suppl 61):1–111. [CSA]
- Isoaho R, Puolijoki H, Huhti E, Kivela S L, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns.Respir Med 1994; 88(8):571–580. [PUBMED], [INFOTRIEVE], [CSA]
- von Hertzen L, Reunanen A, Impivaara O, Mälkiä E, Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease—a nationally representative population study.Respir Med 2000; 94(4):356–363. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kotaniemi J.-T, Lundbäck B, Nieminen M M, Sovijärvi A R.A, Laitinen L A. Increase of asthma in adults in northern Finland? A report from the FinEsS study.Allergy 2001; 56:169–174. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases. A comparative study between northern Sweden and northern Finland: report from the FinEsS study.Chest 2001; 119:852–861. [CSA], [CROSSREF]
- Kotaniemi J.-T, Hassi J, Kataja M, Jönsson E, Laitinen L.-A, Sovijärvi A R.A, Lundbäck B. Does non-responder bias have a significant effect on the results in a postal questionnaire study?Eur J Epidemiol 2002; 17:809–817. [CSA], [CROSSREF]
- Kotaniemi J.-T, Pallasaho P, Sovijärvi A R.A, Laitinen L A, Lundbäck B. Respiratory symptoms and asthma in relation to cold climate, inhaled allergens and irritants.J Asthma 2002; 39(7):649–658. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kotaniemi J T, Latvala J, Lundbäck B, Sovijärvi A, Hassi J, Larsson K. Does living in a cold climate or recreational skiing increase the risk for obstructive respiratory diseases or symptoms?Int J Circumpolar Health May, 2003; 62(2):142–157. [PUBMED], [INFOTRIEVE], [CSA]
- Pallasaho P, Lundbäck B, Läspä S L, Jönsson E, Kotaniemi J, Sovijärvi A R, Laitinen L A. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study.Respir Med Nov., 1999; 93(11):798–809. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lundbäck B. Asthma, chronic bronchitis and respiratory symptoms: prevalence and important determinants. The obstructive lung disease in Northern Sweden Study I.Umeå Univ Med Diss 1993; 387:1–118, Appendix pp. I–xii. [CSA]
- Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Standardized questionaries on respiratory symptoms.Br Med J 1960; ii1665, [CSA]
- Burney P G.J, Laitinen L A, Perdrizet S, Huckauf H, Tattersfield A E, Chinn S, Poisson N, Heeren A, Britton J R, Jones T. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison.Eur Respir J 1989; 2:940–945. [PUBMED], [INFOTRIEVE], [CSA]
- European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS).Eur Respir J 1996; 9:687–695. [CSA], [CROSSREF]
- American Thoracic Society. Standardization of spirometry. 1994 update.Am J Respir Crit Care Med 1995; 152:1107–1136. [CSA]
- Viljanen A. Reference values for spirometric, pulmonary diffusing capacity and body pletysmografic studies.Scand J Clin Lab Invest 1982; 42(Suppl 159):5–20. [CSA]
- Dreborg S. The skin prick test: methodological studies and clinical applications. In: Medical Dissertation No. 239. 1987:1–148, Linköping, Sweden.
- Whittemore A, Perlin S, DiCiccio Y. Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES.Am J Public Health 1995; 85(5):702–706. [PUBMED], [INFOTRIEVE], [CSA]
- Anto J M, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease.Eur Respir J 2001; 17(5):982–994. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD).Respiration 2001; 68(1):4–19. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A C, Jönsson E, Larsson L G, Andersson S, Sandström T, Larsson K. Obstructive lung disease in Northern Sweden studies: not 15 but 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies.Respir Med 2003; 97(2):115–122. [CSA], [CROSSREF]
- Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994.Arch Intern Med Jun. 12, 2000; 160(11):1683–1689. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tylen U, Boijsen M, Ekberg-Jansson A, Bake B, Löfdahl C G. Emphysematous lesions and lung function in healthy smokers 60 years of age.Respir Med 2000; 94(1):38–43. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hardie J A, Buist A S, Vollmer W M, Ellingsen I, Bakke P S, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.Eur Respir J Nov., 2002; 20(5):1117–1122. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?Am J Respir Crit Care Med 2002; 166:329–332. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bobadilla A, Guerra S, Sherrill D, Barbee R. How accurate is the self-reported diagnosis of chronic bronchitis?Chest 2002; 122:1234–1239. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chapman K R, Tashkin D P, Pye D J. Gender bias in the diagnosis of COPD.Chest Jun., 2001; 119(6):1691–1695. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Halbert R J, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease?Chest 2003; 123:1684–1692. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zieliñski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening.Chest 2001; 119:731–736. [CSA], [CROSSREF]
- Lacasse Y, Ferreira I, Brooks D, Newman T, Goldstein R S. Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease.Arch Intern Med Jan. 8, 2001; 161(1):69–74. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]